Status:
COMPLETED
The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Parkinson Disease
Eligibility:
All Genders
Brief Summary
Documentation of the effect of SIFROL® on tremor and depression as well as its tolerability in ambulatory patients suffering from idiopathic Parkinson's disease under routine conditions
Eligibility Criteria
Inclusion
- Patients with idiopathic Parkinson's disease with tremor and/or depression requiring therapy with Sifrol® or change of therapy to Sifro®l and not under medication with neuroleptics were allowed to be observed during the study
Exclusion
- Patients who meet one or more of the general or specific contraindications mentioned in the Summary of Product Characteristics (SPC) for Sifrol®
- Patients under treatment with neuroleptics should not be observed during this study
Key Trial Info
Start Date :
July 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
1464 Patients enrolled
Trial Details
Trial ID
NCT02231294
Start Date
July 1 2000
Last Update
September 4 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.